| Autor: |
Davis SM; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.; eXtraOrdinarY Kids Clinic, Children's Hospital Colorado, Aurora, Colorado, USA., Urban R; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA., Reisz JA; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA., Chan CL; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Kelsey M; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Howell S; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.; eXtraOrdinarY Kids Clinic, Children's Hospital Colorado, Aurora, Colorado, USA., Tartaglia N; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.; eXtraOrdinarY Kids Clinic, Children's Hospital Colorado, Aurora, Colorado, USA., Zeitler P; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.; eXtraOrdinarY Kids Clinic, Children's Hospital Colorado, Aurora, Colorado, USA., Baker Ii P; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA. |
| Abstrakt: |
Conditions related to cardiometabolic disease, including metabolic syndrome and type 2 diabetes, are common among men with Klinefelter syndrome (KS). The molecular mechanisms underlying this aberrant metabolism in KS are largely unknown, although there is an assumption that chronic testosterone deficiency plays a role. This cross-sectional study compared plasma metabolites in 31 pubertal adolescent males with KS to 32 controls of similar age (14 ± 2 years), pubertal stage, and body mass index z-score of 0.1 ± 1.2 and then between testosterone-treated (n = 16) and untreated males with KS. The plasma metabolome in males with KS was distinctly different from that in controls, with 22% of measured metabolites having a differential abundance and seven metabolites nearly completely separating KS from controls (area under the curve > 0.9, P < 0.0001). Multiple saturated free fatty acids were higher in KS, while mono- and polyunsaturated fatty acids were lower, and the top significantly enriched pathway was mitochondrial β-oxidation of long-chain saturated fatty acids (enrichment ratio 16, P < 0.0001). In contrast, there were no observed differences in metabolite concentrations between testosterone-treated and untreated individuals with KS. In conclusion, the plasma metabolome profile in adolescent males with KS is distinctly different from that in males without KS independent of age, obesity, pubertal development, or testosterone treatment status and is suggestive of differences in mitochondrial β-oxidation. |
